Stroke incidence in heart failure and atrial fibrillation: a population-based retrospective cohort study

Nicholas R Jones1, Margaret Smith2, Sarah Lay-Flurrie1

  • 1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford.

Insights

Heart failure (HF) increases stroke risk in atrial fibrillation (AF) patients, but high mortality rates complicate risk assessment. Existing scores may overestimate stroke risk in HF patients due to poor prognosis.

Area of Science:

  • Cardiology
  • Neurology
  • Public Health

Background:

  • Heart failure (HF) is a known risk factor for stroke in patients with atrial fibrillation (AF).
  • Existing stroke risk scores do not adequately account for the poor prognosis associated with HF.
  • This study addresses the prognostic significance of HF in AF patients regarding stroke risk.

Purpose of the Study:

  • To investigate the incidence of stroke in individuals with both HF and AF compared to those with AF alone.
  • To account for the competing risk of death in the analysis of stroke incidence.
  • To evaluate the impact of HF on stroke risk prediction in AF patients.

Main Methods:

  • A population-based retrospective cohort study utilizing English primary care and secondary care data (Hospital Episode Statistics).
  • Included 2,381,941 individuals aged ≥45 years from 2000-2018, analyzing HF and AF as time-varying covariates.
  • Employed Cox and Fine-Gray models to calculate hazard ratios (HRs) for first stroke, considering competing risks.

Main Results:

  • Over a median follow-up of 6.62 years, stroke occurred in 3.9% and death in 13.2% of the cohort.
  • While AF alone showed the highest relative stroke risk (HR 2.43) in the Cox model, HF and AF had a reduced risk (HR 1.48) in the Fine-Gray model, indicating attenuated risk after accounting for mortality.
  • Mortality was high, exceeding 51.3% in individuals with HF.

Conclusions:

  • Heart failure is an etiological risk factor for stroke, but its prognostic impact is diminished by high mortality rates.
  • The CHA2DS2-VASc score may overestimate stroke incidence in some HF patients, particularly those with a poorer prognosis.
  • Accurate stroke risk assessment in AF patients with HF requires consideration of competing mortality risks.
Abstract